<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">Use of stem cells against COVID-19 has been under evaluation in China recently. Additionally, tocilizumab (Roche Pharmaceuticals, Basel, Switzerland) is a monoclonal antibody that is used in the treatment of RA exacerbation. It was designed to inhibit the binding of interleukin-6 to its receptors, thus alleviating cytokine release syndrome. Currently, it is also being investigated for treatment of COVID-19.
 <xref rid="bib54" ref-type="bibr">
  <sup>54</sup>
 </xref>
</p>
